메뉴 건너뛰기




Volumn 2, Issue 4, 2008, Pages 911-916

Rituximab therapy in Greek patients with rheumatoid arthritis

Author keywords

Greek patients; Rheumatoid arthritis; Rituximab

Indexed keywords


EID: 78650790588     PISSN: 11775475     EISSN: 11775491     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (13)

References (31)
  • 1
    • 0023945481 scopus 로고
    • The American Rheumatism Association 1987 revised criteria for classification of rheumatoid arthritis
    • Arnett FC, Edworthy SM, Blonch DA, et al. 1988. The American Rheumatism Association 1987 revised criteria for classification of rheumatoid arthritis. Arthritis Rheum, 31:315-24.
    • (1988) Arthritis Rheum , vol.31 , pp. 315-324
    • Arnett, F.C.1    Edworthy, S.M.2    Blonch, D.A.3
  • 2
    • 0034469156 scopus 로고    scopus 로고
    • A revival of the B-cell paradigm for rheumatoid arthritis pathogenesis
    • Benoist C and Mathis D. 2000. A revival of the B-cell paradigm for rheumatoid arthritis pathogenesis. Arthritis Res, 2:90-4.
    • (2000) Arthritis Res , vol.2 , pp. 90-94
    • Benoist, C.1    Mathis, D.2
  • 5
    • 33746961890 scopus 로고    scopus 로고
    • Efficasy and safety of rituximab in active rheumatoid arthritis patients who experienced an inadequate response to one or more anti-TNF therapies (REFLEX study)
    • Conen S, Emery P, Greenwald M, et al. 2006. Efficasy and safety of rituximab in active rheumatoid arthritis patients who experienced an inadequate response to one or more anti-TNF therapies (REFLEX study). Arthritis Rheum, 54:2793-806.
    • (2006) Arthritis Rheum , vol.54 , pp. 2793-2806
    • Conen, S.1    Emery, P.2    Greenwald, M.3
  • 6
    • 0036676817 scopus 로고    scopus 로고
    • Efficacy of selective B cell blockade in the treatment of rheumatoid arthritis: Evidence for a pathogenic role of B-cells
    • De Vita S, Zaja F, Sacco S, De Candia A, Fanin R, Ferraccioli G, et al. 2002. Efficacy of selective B cell blockade in the treatment of rheumatoid arthritis: evidence for a pathogenic role of B-cells. Arthritis Rheum, 46:2029-33.
    • (2002) Arthritis Rheum , vol.46 , pp. 2029-2033
    • de Vita, S.1    Zaja, F.2    Sacco, S.3    de Candia, A.4    Fanin, R.5    Ferraccioli, G.6
  • 7
    • 0037732689 scopus 로고    scopus 로고
    • The role of B cells in rheumatoid arthritis: Mechanisms and therapeutic targets
    • Dorner T and Burmeister GR. 2003. The role of B cells in rheumatoid arthritis: mechanisms and therapeutic targets. Curr Opin Rheumatol, 15:246-52.
    • (2003) Curr Opin Rheumatol , vol.15 , pp. 246-252
    • Dorner, T.1    Burmeister, G.R.2
  • 8
    • 0026769393 scopus 로고
    • Rheumatoid arthritis in Greek and British patients, a comparative clinical, radiological and serologic study
    • Drosos AA, Lanchbury JS, Panayi GS, Moutsopoulos HM, et al. 1992. Rheumatoid arthritis in Greek and British patients, a comparative clinical, radiological and serologic study. Arthritis Rheum, 35:745-8.
    • (1992) Arthritis Rheum , vol.35 , pp. 745-748
    • Drosos, A.A.1    Lanchbury, J.S.2    Panayi, G.S.3    Moutsopoulos, H.M.4
  • 9
    • 0029113092 scopus 로고
    • Reumatoid arthritis in Greece: Clinical, serological and genetic considerations
    • Drosos AA and Moutsopoulos HM. 1995. Reumatoid arthritis in Greece: clinical, serological and genetic considerations. Clin Exp Rheumatol, 13(Suppl 12):S7-12.
    • (1995) Clin Exp Rheumatol , vol.13 , Issue.SUPPL. 12
    • Drosos, A.A.1    Moutsopoulos, H.M.2
  • 10
    • 0033033201 scopus 로고    scopus 로고
    • Do selfperpetueting B lymphocytes drive human autoimmune disease?
    • Edwards JCW, Cambridge G, Abrahams VM, et al. 1999. Do selfperpetueting B lymphocytes drive human autoimmune disease? Immunology, 97:188-96.
    • (1999) Immunology , vol.97 , pp. 188-196
    • Edwards, J.C.W.1    Cambridge, G.2    Abrahams, V.M.3
  • 11
    • 0035093233 scopus 로고    scopus 로고
    • Sustained improvement on rheumatoid arthritis following a protocol designed to deplete B lympocytes
    • Edwards JCW and Cambridge G. 2001. Sustained improvement on rheumatoid arthritis following a protocol designed to deplete B lympocytes. Rheumatology, 40:205-11.
    • (2001) Rheumatology , vol.40 , pp. 205-211
    • Edwards, J.C.W.1    Cambridge, G.2
  • 12
    • 2942537697 scopus 로고    scopus 로고
    • Efficasy of B-cell targeted therapy with rituximab in patients with rheumatoid arthritis
    • Edwards JCW, Szczepanski L, Szechinski J, et al. 2004. Efficasy of B-cell targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med, 350:2572-81.
    • (2004) N Engl J Med , vol.350 , pp. 2572-2581
    • Edwards, J.C.W.1    Szczepanski, L.2    Szechinski, J.3
  • 13
    • 19944433874 scopus 로고    scopus 로고
    • Results from a nationwide postmarketing cohort study of patients in Sweden treated with etanercept
    • Feltelius N, Fored CM, Blomqvist P, et al. 2005. Results from a nationwide postmarketing cohort study of patients in Sweden treated with etanercept. Ann Rheum Dis, 64:246-52.
    • (2005) Ann Rheum Dis , vol.64 , pp. 246-252
    • Feltelius, N.1    Fored, C.M.2    Blomqvist, P.3
  • 14
    • 47349108026 scopus 로고    scopus 로고
    • Infusion-associated events decrease with repeat courses of rituximab in patients with active rheumatoid arthritis
    • Fleischmann, Van Vollenhoven R, Udell J, et al. 2006. Infusion-associated events decrease with repeat courses of rituximab in patients with active rheumatoid arthritis. Arthritis Rheum, 54(Suppl):S238.
    • (2006) Arthritis Rheum , vol.54 , Issue.SUPPL.
    • Fleischmann1    van Vollenhoven, R.2    Udell, J.3
  • 15
    • 0035050214 scopus 로고    scopus 로고
    • Role of B-cells in the pathogenesis of rheumatoid arthritis: Potential implication of treatment
    • Gause A, Berek C. Role of B-cells in the pathogenesis of rheumatoid arthritis: potential implication of treatment. Bio-Drugs, 2001;15:73-9.
    • (2001) Bio-Drugs , vol.15 , pp. 73-79
    • Gause, A.1    Berek, C.2
  • 17
    • 34447329384 scopus 로고    scopus 로고
    • Long-term efficacy and safety of a repeat treatment course of rituximab in RA patients with an inadequate response to one or more TNF inhibitors
    • Keystone E, Fleischmann RM, Emery P, et al. 2006. Long-term efficacy and safety of a repeat treatment course of rituximab in RA patients with an inadequate response to one or more TNF inhibitors. Arthritis Rheum, (54 Suppl):S328.
    • (2006) Arthritis Rheum , Issue.54 SUPPL.
    • Keystone, E.1    Fleischmann, R.M.2    Emery, P.3
  • 18
    • 1042290332 scopus 로고    scopus 로고
    • Once-weekly administration of 50 mf of etanrecept in patients with active RA: Results of a multicenter, randomized, double-blind, placebo-controlled trial
    • Keystone EC, Schiff MH, Kremer JM, et al. 2004. Once-weekly administration of 50 mf of etanrecept in patients with active RA: results of a multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheum, 50:353-63.
    • (2004) Arthritis Rheum , vol.50 , pp. 353-363
    • Keystone, E.C.1    Schiff, M.H.2    Kremer, J.M.3
  • 19
    • 0034469424 scopus 로고    scopus 로고
    • B-cells in rheumatoid arthritis
    • Kim HJ and Berek C. 2000. B-cells in rheumatoid arthritis. Arthritis Res, 2:126-31.
    • (2000) Arthritis Res , vol.2 , pp. 126-131
    • Kim, H.J.1    Berek, C.2
  • 20
    • 0037129969 scopus 로고    scopus 로고
    • Rheumatoid arthritis-a molecular understanding
    • Lawrence JB and Haynes MK. 2002. Rheumatoid arthritis-a molecular understanding. Ann Intern Med, 136:908-22.
    • (2002) Ann Intern Med , vol.136 , pp. 908-922
    • Lawrence, J.B.1    Haynes, M.K.2
  • 21
    • 0031968825 scopus 로고    scopus 로고
    • Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States
    • Lawrence RC, Helmick CG, Arnett FC, et al. 1998. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum, 41:778-9.
    • (1998) Arthritis Rheum , vol.41 , pp. 778-779
    • Lawrence, R.C.1    Helmick, C.G.2    Arnett, F.C.3
  • 22
    • 0034735842 scopus 로고    scopus 로고
    • Infliximab and methotrexate in the treatment of rheumatoid arthritis
    • Lipsky PE, Van der Heijde DM, St Clair EW, et al. 2000. Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med, 343:1594-602.
    • (2000) N Engl J Med , vol.343 , pp. 1594-1602
    • Lipsky, P.E.1    van der Heijde, D.M.2    St Clair, E.W.3
  • 23
    • 24944472774 scopus 로고    scopus 로고
    • B-cells: A fundamental role in the pathogenesis of rheumatoid arthritis?
    • Panagyi GS. 2005. B-cells: a fundamental role in the pathogenesis of rheumatoid arthritis? Rheumatology (Oxford), 44(Suppl 2):ii3-ii7.
    • (2005) Rheumatology (Oxford) , vol.44 , Issue.SUPPL. 2
    • Panagyi, G.S.1
  • 24
    • 0021212076 scopus 로고
    • Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years
    • Pincus T, Callahan LF, Sale WG, et al. 1984. Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. Arthritis Rheum, 27:864-72.
    • (1984) Arthritis Rheum , vol.27 , pp. 864-872
    • Pincus, T.1    Callahan, L.F.2    Sale, W.G.3
  • 25
    • 0035463152 scopus 로고    scopus 로고
    • Presence of a population of CD20p, CD38-B lymphocytes with defective proliferative responsivness in the synovial compartment of patients with rheumatoid arthritis
    • Reparon-Schuijt CC, Van Esch WJ, Van Kooten C, et al. 2001. Presence of a population of CD20p, CD38-B lymphocytes with defective proliferative responsivness in the synovial compartment of patients with rheumatoid arthritis. Arthritis Rheum, 44:2029-37.
    • (2001) Arthritis Rheum , vol.44 , pp. 2029-2037
    • Reparon-Schuijt, C.C.1    van Esch, W.J.2    van Kooten, C.3
  • 26
    • 0034473683 scopus 로고    scopus 로고
    • Epidemiology of rheumatic diseases
    • Sangha O. 2001. Epidemiology of rheumatic diseases. Rheumatology (Oxford), 39(Suppl):3-12.
    • (2001) Rheumatology (Oxford) , vol.39 , Issue.SUPPL. , pp. 3-12
    • Sangha, O.1
  • 27
    • 0037255527 scopus 로고    scopus 로고
    • Clonal analysis of B cells in the synovial membrane of patients with rheumatoid arthritis
    • Shiokawa S, Matsumoto N, Nishimura J, et al. 2003. Clonal analysis of B cells in the synovial membrane of patients with rheumatoid arthritis. Scand J Rheumatol, 32:12-8.
    • (2003) Scand J Rheumatol , vol.32 , pp. 12-18
    • Shiokawa, S.1    Matsumoto, N.2    Nishimura, J.3
  • 28
    • 0035888030 scopus 로고    scopus 로고
    • T-cell activation in rheumatoid synovium is B-cell dependent
    • Takemura S, Klimiuk PA, Braun A, et al. 2001. T-cell activation in rheumatoid synovium is B-cell dependent. J Immunol., 167:4710-8.
    • (2001) J Immunol. , vol.167 , pp. 4710-4718
    • Takemura, S.1    Klimiuk, P.A.2    Braun, A.3
  • 29
    • 0141923537 scopus 로고    scopus 로고
    • B lymphocytes contribute to autoimmune disease pathogenesis: Current trends and clinical implications
    • Tuscano JM, Harris GS, Tedder TF, et al. 2003. B lymphocytes contribute to autoimmune disease pathogenesis:current trends and clinical implications. Autoimmun Rev, 2:101-8.
    • (2003) Autoimmun Rev , vol.2 , pp. 101-108
    • Tuscano, J.M.1    Harris, G.S.2    Tedder, T.F.3
  • 30
    • 0037231533 scopus 로고    scopus 로고
    • Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: The ARMADA trial
    • Weinblatt ME, Keystone EC, Furst DE, et al. 2003. Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial. Arthritis Rheum, 48:35-45.
    • (2003) Arthritis Rheum , vol.48 , pp. 35-45
    • Weinblatt, M.E.1    Keystone, E.C.2    Furst, D.E.3
  • 31
    • 0035001641 scopus 로고    scopus 로고
    • Pathogenesis of rheumatoid arthritis. Role of B lymphocytes
    • Zhang Z and Bridges SL. 2001. Pathogenesis of rheumatoid arthritis. Role of B lymphocytes. Rheum Disease Clin North Am, 27:335-53.
    • (2001) Rheum Disease Clin North Am , vol.27 , pp. 335-353
    • Zhang, Z.1    Bridges, S.L.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.